Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ELI LILLY AND COMPANY

(LLY)
  Report
Real-time Estimate Cboe BZX  -  01:36 2022-10-05 pm EDT
331.68 USD   +0.54%
10:46aFresenius Plans Expansion Into Early Kidney Care
MT
09/29Oncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Trial
MT
09/28Biogen shares soar on landmark Alzheimer's data
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ELI LILLY AND COMPANY : Ex-dividend day for

08/12/2022 EDT

A dividend is removed today from Eli Lilly and Company's share.



© Factset 2022
All news about ELI LILLY AND COMPANY
10:46aFresenius Plans Expansion Into Early Kidney Care
MT
09/29Oncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Tria..
MT
09/28Biogen shares soar on landmark Alzheimer's data
RE
09/28Eli Lilly Up Over 7%, on Track for Record High Close -- Data Talk
DJ
09/28MarketScreener's World Press Review : September 28, ..
MS
09/28Thermo Fisher Scientific's Cancer Screening Technology Gets FDA Approval
MT
09/27Eisai says Alzheimer's drug succeeds in slowing cognitive decline
RE
09/27Eli Lilly Faces US Lawsuit Over Age Discrimination In Sales Jobs
MT
09/26Eli Lilly sued for age discrimination by U.S. agency EEOC
RE
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
More news
Analyst Recommendations on ELI LILLY AND COMPANY
More recommendations
Financials (USD)
Sales 2022 28 822 M - -
Net income 2022 6 377 M - -
Net Debt 2022 10 150 M - -
P/E ratio 2022 47,8x
Yield 2022 1,16%
Capitalization 313 B 313 B -
EV / Sales 2022 11,2x
EV / Sales 2023 10,6x
Nbr of Employees 35 000
Free-Float 99,7%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 329,89 $
Average target price 337,76 $
Spread / Average Target 2,39%
EPS Revisions
Managers and Directors
David A. Ricks Chairman, President & Chief Executive Officer
Anat Ashkenazi Chief Financial Officer & Senior Vice President
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Diogo Rau Senior VP, Chief Information & Digital Officer
Alonzo Weems Senior VP, Chief Ethics & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ELI LILLY AND COMPANY16.41%313 453
JOHNSON & JOHNSON-3.19%435 445
ROCHE HOLDING AG-12.23%279 092
ABBVIE INC.4.87%251 052
PFIZER, INC.-24.71%249 525
NOVO NORDISK A/S6.91%238 512